Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...

Zeroing in on Eli Lilly, the company is already well established with Zepbound, which should continue to sell briskly as the world waits for a more powerful and efficacious obesity drug to hit the ...

Eli Lilly (NYSE:LLY) recently announced its plans to invest $27 billion in four new U.S. manufacturing plants over the next five years, creating thousands of jobs. This move comes at a time when ...

The UK medicines regulator approved Eli Lilly's Alzheimer's disease therapy ... which has launched a campaign to ask the public to lobby their MPs to attend a meeting in December to raise ...

David Ricks, CEO of Eli Lilly (NYSE:LLY), Robert Davis ... Stephen Ubl, CEO of the pharma lobby group Pharmaceutical Research and Manufacturers of America (PhRMA), also attended the meeting.